The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Nicotinamide Mononucleotide Adenylyltransferase Expression in Mitochondrial Matrix Delays Wallerian Degeneration
Open accessAbstract
Studies of naturally occurring mutant mice,wld s, showing delayed Wallerian degeneration phenotype, suggest that axonal degeneration is an active process. We previously showed that increased nicotinamide adenine dinucleotide (NAD)-synthesizing activity by overexpression of nicotinamide mononucleotide adenylyltransferase (NMNAT) is the essential component of the Wld s protein, the expression of which is responsible for the delayed Wallerian degeneration phenotype in wld smice. Indeed, NMNAT overexpression in cultured neurons provides robust protection to neurites, as well. To examine the effect of NMNAT overexpression in vivo and to analyze the mechanism that causes axonal protection, we generated transgenic mice (Tg) overexpressing NMNAT1 (nuclear isoform), NMNAT3 (mitochondrial isoform), or the Wld s protein bearing a W258A mutation, which disrupts NAD-synthesizing activity of the Wld s protein. Wallerian degeneration delay in NMNAT3-Tg was similar to that in wld smice, whereas axonal protection in NMNAT1-Tg or Wld s(W258A)-Tg was not detectable. Detailed analysis of subcellular localization of the overexpressed proteins revealed that the axonal protection phenotype was correlated with localization of NMNAT enzymatic activity to mitochondrial matrix. Furthermore, we found that isolated mitochondria from mice showing axonal protection expressed unchanged levels of respiratory chain components, but were capable of increased ATP production. These results suggest that axonal protection by NMNAT expression in neurons is provided by modifying mitochondrial function. Alteration of mitochondrial function may constitute a novel tool for axonal protection, as well as a possible treatment of diseases involving axonopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In mammals, over-expressing NMNATs significantly delays Wallerian degeneration of peripheral nerves (28)(29)(30)(31)(32)(33).”
From CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy (2012) · cites this paper as [33]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“NMNAT3-transgenic mice show delayed Wallerian degeneration similar to Wld S mice (33).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficient selection for high-expression transfectants with a novel eukaryotic vector
Niwa, H., Yamamura, K., & Miyazaki, J. (1991) · Gene · doi:10.1016/0378-1119(91)90434-d · Cited by 5,149
Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
Araki, T., Sasaki, Y., & Milbrandt, J. (2004) · Science · doi:10.1126/science.1098014 · Cited by 1,060 · cited 12×
“We showed that exogenously applied NAD results in activation of Sirt1, an NADdependent protein deacetylase, and discussed that this is the key mechanism that connects increased NMNAT activity and axonal protection (Araki et al., 2004).”
BackgroundMethodResultInfluentialSelf-citationPoly(ADP-ribosyl)ation by PARP-1: `PAR-laying' NAD + into a nuclear signalPreprint
Kim, M. Y., Zhang, T., & Kraus, W. L. (2005) · Genes & Development · doi:10.1101/gad.1331805 · Cited by 826
Axonal Self-Destruction and Neurodegeneration
Raff, M., Whitmore, A., & Finn, J. (2002) · Science · doi:10.1126/science.1068613 · Cited by 670 · cited 1×
“Since NMNAT2 is constitutively expressed highly in neurons (Raffaelli et al., 2002), we decided to generate mice that overexpress mammalian NMNAT orthologs other than NMNAT2 (i.e., NMNAT1 and NMNAT3, either of which are unexpressed in neurons) (Emanuelli et al., 2001; Zhang et al., 2003).”
BackgroundAbsence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve
Lunn, E. R., Perry, V. H., Brown, M. C., Rosen, H., & Gordon, S. (1989) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1989.tb00771.x · Cited by 646
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene
Mack, T. G. A., Reiner, M., Beirowski, B., Mi, W., Emanuelli, M., Wagner, D., Thomson, D., Gillingwater, T., Court, F., Conforti, L., et al. (2001) · Nature Neuroscience · doi:10.1038/nn770 · Cited by 611
Berger, F., Lau, C., Dahlmann, M., & Ziegler, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508660200 · Cited by 508 · cited 5×
“Previous reports suggest that NMNAT3 is located mainly, but not exclusively, in mitochondria when it is transiently overexpressed in cultured cells (Zhang et al., 2003; Berger et al., 2005); however, we found that NMNAT3 was located almost exclusively in mitochondria of NMNAT3-Tg mice.”
BackgroundInfluentialSirtuin Functions in Health and Disease
Yamamoto, H., Schoonjans, K., & Auwerx, J. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0079 · Cited by 480 · cited 2×
“However, it was not clear how NMNAT overexpression affects Sirt1 activity, because, whereas Sirt1 activity is strictly dependent on intracellular NAD levels (Yamamoto et al., 2007), overexpression of NMNAT activity does not cause major changes in NAD levels (Mack et al.”
BackgroundSuter, M., Riek, U., Tuerk, R. D., Schlattner, U., Wallimann, T., & Neumann, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606357200 · Cited by 473 · cited 2×
“anion-exchange column as described previously (Suter et al., 2006).”
MethodSims, N. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04189.x · Cited by 388 · cited 1×
“Mitochondria were isolated from cerebrum as described previously with minor modifications (Sims, 1990; Rajapakse et al., 2001) (also shown in supplemental Fig.”
Method
Cited by
Sorted by citations
Items 101–144 of 144
Increased ROS Level in Spinal Cord of Wobbler Mice due to Nmnat2 Downregulation
Röderer, P., Klatt, L., John, F., Theis, V., Winklhofer, K. F., Theiß, C., & Matschke, V. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0999-7 · Cited by 22
Mao, X. R., Kaufman, D. M., & Crowder, C. M. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.5 · Cited by 23
“The mitochondrially localized mammalian isoform Nmnat3 has been shown to phenocopy the axonal degeneration-protective activity of the Nmnat1 wlds mutant, whereas simple overexpression of the nuclear-localized Nmnat1 or the golgi-localized Nmnat2 does not protect from axonal degeneration.(8,41) The axonal-protective ph…”
BackgroundOverexpression of Nmnat improves the adaption of health span in aging Drosophila
Xianchu, L., Liu, M., Tang, C., Xiang, Z., Li, Q., Ruan, X., Xiong, K., & Zheng, L. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.04.026 · Cited by 22
“Nmnat plays an essential role in maintaining axonal integrity by modifying mitochondrial function, and Nmnat expression in mitochondrial matrix delays Wallerian degeneration (Yahata et al., 2009; Fang et al., 2012).”
NMNAT3 is protective against the effects of neonatal cerebral hypoxia‐ischemia
Galindo, R., Greenberg, M. B., Araki, T., Sasaki, Y., Mehta, N., Milbrandt, J., & Holtzman, D. M. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.450 · Cited by 23
“1B and D) consistent with the prior observation demonstrating that NMNAT3 is mainly localized to the mitochondrial compartment in these mice.(15)”
BackgroundMethodResultInfluentialSelf-citationBenefits of Enhancing Nicotinamide Adenine Dinucleotide Levels in Damaged or Diseased Nerve CellsPreprint
Pieper, A. A., & McKnight, S. L. (2018) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2018.83.037622 · Cited by 20
“Although initially found to be most highly abundant in the nucleus, theWldS fusion protein was later noted to also be enriched in mitochondria, cytosol, peroxisomes/lysosomes, endoplasmic reticulum, and axons (Yahata et al. 2009; Avery et al. 2012; Wang et al. 2015).”
BackgroundWright, A. K., Wishart, T. M., Ingham, C. A., & Gillingwater, T. H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015108 · Cited by 13
“…of action of Wld S have highlighted several potential effector pathways and sub-cellular targets that may be suitable as therapeutic targets [28], including; Nmnat-dependent pathways [18,45–46], mitochondria [31,47–48], VCP-dependent pathways [49,50], and cell cycle/cell stress pathways [32,51].”
BackgroundAdvances of Glycometabolism Engineering in Chinese Hamster Ovary Cells
Zhang, H.-Y., Fan, Z., & Wang, T. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.774175 · Cited by 19
Kline, R. A., Dissanayake, K. N., Hurtado, M. L., Martínez, N. W., Åhl, A., Mole, A. J., Lamont, D., Court, F., Ribchester, R., Wishart, T., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104496 · Cited by 16
“It has been shown that over-expression of the mitochondrially localized form of Nicotinamide mononucleotide adenylyltransferase, Nmnat3, can protect axons from injury in both mouse and drosophila models (Avery et al., 2012; Berger et al., 2005; Yahata et al., 2009).”
Beirowski, B., Morreale, G., Conforti, L., Mazzola, F., Stefano, M. D., Wilbrey, A. L., Babetto, E., Janečková, L., Magni, G., & Coleman, M. P. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.12.024 · Cited by 19
Lost in elimination: mechanisms of axonal loss
Misgeld, T. (2011) · e-Neuroforum · doi:10.1007/s13295-011-0017-2 · Cited by 13
Evans, C., Cook, S. J., Coleman, M. P., & Gilley, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076505 · Cited by 9
“to be enhanced in Wld mice and in transgenic flies expressing Wld [35,36].”
BackgroundSirtuins in Aging and Age-Related Diseases
Haigis, M. C., & Sinclair, D. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-378638-8.00011-7 · Cited by 13
Xu, Y., Lu, A., Guan, X., Ying, T., Pan, J., Tan, M., & Lu, J. (2024) · Food Frontiers · doi:10.1002/fft2.511 · Cited by 11
Fertility protection during chemotherapy treatment by boosting the NAD(P)+ metabolome
Ho, W.-H. J., Marinova, M. B., Listijono, D. R., Bertoldo, M. J., Richani, D., Kim, L., Brown, A., Riepsamen, A. H., Cabot, S., Frost, E. R., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00119-w · Cited by 14
“1F), which localises to the nucleus (Yahata et al, 2009).”
MethodSelf-citationAvery, M., Rooney, T., Pandya, J. D., Wishart, T., Gillingwater, T., Geddes, J. W., Sullivan, P., & Freeman, M. (2012) · Current Biology · doi:10.1016/j.cub.2012.02.043 · Cited by 13
“This change in bioenergetics, coupled with increased mitochondrial motility in WldS+ axons, might enhance distribution of ATP or other mitochondriallyderived metabolites.”
InfluentialBeirowski, B. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105751 · Cited by 15
Parsons, R. B., Kocinaj, A., Ruiz-Pulido, G., Prendergast, S. A., Parsons, A. E., Facey, P. D., & Hirth, F. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac077 · Cited by 13
“Earlier reports revealed the ability of NMNAT3 in preventing axonal degeneration where its ectopic expression delayed degeneration of transected sciatic nerves of mice, an effect not reproduced by NMNAT1 expression (22).”
BackgroundAcquired axonal degeneration and regeneration
Benarroch, E. E. (2015) · Neurology · doi:10.1212/wnl.0000000000001601 · Cited by 24
“In the mitochondria, both WLD/ NMNAT1 and NMNAT3 promote mitochondrial motility and increase the Ca(21)-buffering activity of mitochondria and this may contribute to its ability to delay axonal degeneration following injury.(20) Genetic studies have identified other pathways that also regulate axonal survival.”
Backgroundvan Lier, M., Smit‐Rigter, L. A., Krimpenfort, R., Saiepour, M. H., Ruimschotel, E., Kamphuis, W., Heimel, J. A., & Levelt, C. N. (2019) · eNeuro · doi:10.1523/eneuro.0277-18.2018 · Cited by 16
“To test this possibility, we examined whether OD plasticity was reduced in a transgenic mouse line overexpressing nuclear NMNAT1 (Yahata et al., 2009).”
BackgroundMethodInfluentialNarne, P., & Phanithi, P. B. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01287-4 · Cited by 9
“Concurrent with this, is an increased ATP generation in isolated mitochondria with no alteration in ETC components (Yahata et al. 2009).”
BackgroundFunakoshi, M., & Araki, T. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.11.002 · Cited by 6
Self-citationTokunaga, S., & Araki, T. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22792 · Cited by 7
“It was shown that the N-terminal 70-amino-acid stretch of WldS protein may contribute to association with other proteins and/or affect the conformation and subcellular localization of WldS protein (Wilbrey et al., 2008; Yahata et al., 2009).”
BackgroundInfluentialSelf-citationExpression of the neuroprotective slow Wallerian degeneration (Wld S ) gene in non-neuronal tissues
Wishart, T. M., Brownstein, D. G., Thomson, D., Tabakova, A. M., Boothe, K., Tsao, J. W., & Gillingwater, T. H. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-148 · Cited by 6
“These data demonstrate that downstream consequences of WldS expression, incorporating pathways including NAD biosynthesis, ubiquitination, the mitochondrial proteome, cell cycle status and cell stress [17,26-28], do not have any major adverse effects on non-neuronal organs.”
Neissi, M., Sheikh‐Hosseini, M., Mohammadi‐Asl, M., Al‐Badran, A. I., Roghani, M., Asl, J. M., & Jorfi, K. (2024) · Clinical Case Reports · doi:10.1002/ccr3.9506 · Cited by 6
“15 Research on NMNAT1 has revealed intriguing findings, including the observation that homozygous null mutations in this gene, seen in both Drosophila melanogaster and murine models, lead to early lethality.”
NAD + repletion rescues female fertility during reproductive ageingPreprint
Bertoldo, M. J., Listijono, D. R., Ho, W.-H. J., Riepsamen, A. H., Jin, X. L., Selesniemi, K. L., Goss, D. M., Mahbub, S. B., Campbell, J. M., Habibalahi, A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/721985 · Cited by 2
Self-citationCheng, F., Zhao, M., Wang, Q., Xiong, H., Yu, K., Chen, C., Zhu, Y., Chen, Y., & Li, J. (2025) · Redox Report · doi:10.1080/13510002.2025.2565033 · Cited by 5
“Substantial protective effects have also been observed by overexpressing NMNAT3 in transgenic mice and Drosophila [56,57].”
Glycolytic System in Axons Supplement Decreased ATP Levels after Axotomy of the Peripheral Nerve
TAKENAKA, T., Ohnishi, Y., Yamamoto, M., Setoyama, D., & Kishima, H. (2023) · eNeuro · doi:10.1523/eneuro.0353-22.2023 · Cited by 5
“It was also reported that mitochondrial localization of NMNAT activity results in increased ATP synthetic capacity without affecting the expression of the mitochondrial enzymes profile of the respiratory chain (Yahata et al., 2009), and increased NMNAT activity delayed WD (Araki et al., 2004).”
BackgroundTargeted deletion of Nmnat1 in mouse retina leads to early severe retinal dystrophyPreprint
Wang, X., Yu, F. H. Z., Liao, R., & Wang, T. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/210757 · Cited by 2
“The axon protection conferred by NMNAT1 seems to be closely related to mitochondria, which is a critical organelle for the maintenance of redox state (59, 60).”
BackgroundAlla, B., Marina, M., Tatyana, E., Semen, V. P., Natalia, A. S., Olesya, S., Alyona, I., Andrei, V. S., & Alexander, A. (2011) · InTech eBooks · doi:10.5772/29157 · Cited by 3
“Overexpression of NMNAT in the mitochondrial matrix resulted in suppression of axonal degeneration seen in neurodenegeration (Sasaki & Milbrandt, 2010; Sasaki et al., 2009; Yahata et al., 2009).”
BackgroundTakada, H., Yuasa, S., & Araki, T. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07783.x · Cited by 4
“Tissue processing for histological analysis Histological analysis of nerve tissues on semi-thin sections and by electron microscopy was performed as described previously (Yahata et al., 2009).”
MethodSelf-citationThe Roles of Moonlighting Nicotinamide Mononucleotide Adenylyl Transferases in Cell Physiology
Lee, Y., & Lin, S.-J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189098 · Cited by 2
“Another in vivo study shows that neuroprotection is observed only in mNMNAT3-transgenic mice, not in mNMNAT1-transgenic mice [108].”
Raches, D. W., Xiao, S., Kusumanchi, P., Yalowitz, J. A., Sanghani, P. C., Long, E. C., Antony, A. C., & Jayaram, H. N. (2011) · Medicinal Chemistry · doi:10.2174/157340611797928262 · Cited by 2
Lu, X.-Q., Zhang, R.-Y., Xu, X.-W., Guang, Y., & Miao, C.-Y. (2010) · Academic Journal of Second Military Medical University · doi:10.3724/sp.j.1008.2010.01251 · Cited by 2
Lee, Y., Huang, C.-C., McDaniel, M., Huang, K., Lee, L.-H., Lao, G., Karthi, D., & Lin, S.-J. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111456 · Cited by 2
“In flies and mice, NMNAT exerts neuronal protection via its chaperone activity (25–27).”
What Is the Role of Mitochondrial Dysfunction in Programmed Axon Death?
Benarroch, E. E. (2022) · Neurology · doi:10.1212/wnl.0000000000200691 · Cited by 1
“Studies in transgenic mice overexpressing NMNAT3 or WLD showed that localization of the enzymatic activity to the mitochondrial matrix is necessary to provide axonal protection by increasing adenosine triphosphate (ATP) production.(25) However, NMNAT2 is the main isoform required for maintenance of healthy axons(26) a…”
BackgroundEx Vivo Analysis of Axonal Degeneration Using Sciatic and Optic Nerve Preparations
López‐Leal, R., & Court, F. A. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0585-1_14 · Cited by 6
Autophagy in ocular health and disease: From mechanistic insights to therapeutic perspectives
Wei, B., Lin, Y., Yang, Y., Zhang, C., Gao, S., Zhao, Q., wang, Y., Han, Z., Xu, D., & Wei, L. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.111288
Zhang, Z., Zhang, X., Wang, Y., Li, Y., Ding, G., Tong, H., Xu, J., Li, C., Wang, X., & Gu, H. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.110999
Spezia, M. C., Dy, C. J., Farrell, B. A., Iftikhar, A., DeMartini, S., Pérez, R., Achilefu, S., & Brogan, D. M. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1657209
“The WldS mutation is a gain-of-function mutation that results in increased nicotinamide mononucleotide adenylyltransferase (NMNAT) activity (Yahata et al., 2009; Sasaki et al., 2009a; Avery et al., 2009).”
Genes Required for Wallerian Degeneration Also Govern Dendrite Degeneration: A Dissertation
Rooney, T. M. (2015) · eScholarship@UMassChan · doi:10.13028/m2wg69
Wakatsuki, S., & Araki, T. (2015) · Springer eBooks · doi:10.1007/978-4-431-54541-5_8
Self-citationdSarm/Sarm1 Governs a Conserved Axon Death Program: A Dissertation
Osterloh, J. M. (2013) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2xs4z
“In mammals, there are 3 homologs of Nmnat: Nmnat1, which is in the nucleus; Nmnat2, which is in the golgi; and Nmnat3, which is mitochondrial (Berger et al., 2005; Lau et al., 2010).”
BackgroundInfluentialAntenor‐Dorsey, J. A. V. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7h70cv2
“Similar results are true for Nmnat3, a mitochondrially localized isoform of Nmnat [158].”
ResultAxon Death Prevented: Wlds and Other Neuroprotective Molecules: A Dissertation
Avery, M. A. (2010) · eScholarship@UMassChan · doi:10.13028/ejya-6w71
Metadata
- Authors
- Yahata, N., Yuasa, S., & Araki, T.
- Affiliations
- National Center of Neurology and Psychiatry (JP)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2009-05-13
- Volume
- 29
- Issue
- 19
- Pages
- 6276-6284
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6665489
- OpenAlex
- W2037726118
- Cited by
- 154
- References
- 30
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 6 · 2021: 10 · 2020: 5 · 2019: 8 · 2018: 10 · 2017: 8 · 2016: 5 · 2015: 10 · 2014: 12 · 2013: 16 · 2012: 16
- FWCI
- 7.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Suzuken Memorial Foundation
- Kowa Company
- Kowa Life Science Foundation
- Astellas Pharma
- National Institute of Biomedical Innovation
- Astellas Foundation for Research on Metabolic Disorders
- Mishima Kaiun Memorial Foundation
- Japan Society for the Promotion of Science (19650089)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- nicotinamide mononucleotide adenylyltransferase, NMNAT3, NMNAT1, Wallerian degeneration, axonal degeneration, axonal protection, mitochondrial matrix, NAD biosynthesis, mitochondrial function, ATP production, transgenic mice, axonopathy
- MeSH terms
- Adenosine Triphosphate, Animals, Axons, Electron Transport, Mice, Transgenic, Mitochondria, Nerve Tissue Proteins, Neurons, Nicotinamide-Nucleotide Adenylyltransferase, Sciatic Nerve, Wallerian Degeneration, Mutation, Missense, Sciatic Neuropathy, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review